Cannabix Technologies' Marijuana Breath Test Device Passes FCC Emissions Testing, Advances Toward U.S. and Canadian Market Entry
核心洞察
Cannabix Technologies' handheld Breath Collection Unit has successfully passed electronic emissions testing required by the FCC and Canadian regulators, marking a key regulatory milestone toward commercialization.
The device, paired with proprietary Breath Cartridges, forms the core hardware of a Marijuana Breath Test system designed to collect stable breath samples for detecting recent THC use.
The company is partnering with Omega Laboratories to advance commercialization using liquid chromatography-mass spectrometry analysis for forensic-level detection.
Cannabix Technologies Inc. (搜索) has achieved a significant regulatory milestone with its handheld Breath Collection Unit (BCU) successfully passing electronic emissions testing required by the Federal Communications Commission (搜索) (FCC) and Canadian regulators. The approval brings the company's Marijuana Breath Test (MBT) system closer to commercial availability in North American markets.
The BCU received an ISO/IEC 17025 accredited test report confirming compliance with electronic emissions standards under CFR Title 47 FCC Part 15 for the U.S. market and ICES-003 Issue 7 standards published by Innovation, Science and Economic Development Canada (搜索) (ISED). Testing was conducted at QAI Laboratories (搜索) in British Columbia, an accredited facility with Telecommunication Certification Body designation by the FCC.
Technology Platform and Design
The Marijuana Breath Test system incorporates Cannabix's proprietary Breath Collection Unit and single-use Breath Cartridge technologies, designed to collect and preserve breath samples for analysis using liquid chromatography-mass spectrometry (LC-MS) methods. The handheld device is engineered to capture stable breath samples that can detect recent delta-9 THC (搜索) use, the primary psychoactive ingredient in cannabis.
Engineering work over recent months focused on device design updates to meet compliance requirements for anticipated commercialization. Electronic emissions testing is required by the FCC for electronic devices that emit radio frequency energy before they can be marketed or sold in the United States, with similar requirements in Canada through ISED.
Strategic Partnership and Market Applications
Cannabix has established a strategic partnership with Omega Laboratories Inc. (搜索), a global leader in forensic drug testing with over 25 years of experience. Omega holds multiple federal and international certifications and operates facilities with extensive experience in novel drug detection technologies. The partnership aims to advance commercialization of the MBT system for customers in the U.S. and Canada.
The breath testing technology focuses on recent marijuana use detection and is intended for deployment across workplaces, law enforcement agencies, and other settings where identifying recent THC use is relevant for safety and compliance purposes. The system is designed to provide forensic-level analysis capabilities for organizations requiring reliable detection methods.
Regulatory Pathway and Commercial Timeline
The successful completion of emissions testing represents a foundational requirement before the device can be marketed or sold in North America. Cannabix is completing the necessary regulatory steps required for both U.S. and Canadian markets as part of its commercialization strategy.
The company, which also develops alcohol breath-testing technologies through its BreathLogix autonomous screening device, positions the marijuana breath test platform as addressing critical needs in workplace safety and law enforcement applications where recent cannabis use detection is essential.